Brain and spinal cord cancer market is growing at a considerable CAGR of 9.0% during the forecast period. Increasing R&D on therapies associated with brain cancer is one of the prime factors affecting and driving the market. Growing demand for minimally invasive surgeries, increased spending on healthcare infrastructure by government among others is also estimated […]
